Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Mary M. Moran"'
Autor:
Manuela Di Fusco, Xiaowu Sun, Mary M. Moran, Henriette Coetzer, Joann M. Zamparo, Mary B. Alvarez, Laura Puzniak, Ying P. Tabak, Joseph C. Cappelleri
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-16 (2023)
Abstract Background Longitudinal estimates of long COVID burden during Omicron remain limited. This study characterized long-term impacts of COVID-19 and booster vaccination on symptoms, Health-Related Quality of Life (HRQoL), and Work Productivity A
Externí odkaz:
https://doaj.org/article/b2b3fd0b3cb14cf0af5bdac630cc1afc
Autor:
Leah J. McGrath, Mary M. Moran, Tamuno Alfred, Maya Reimbaeva, Manuela Di Fusco, Farid Khan, Verna L. Welch, Deepa Malhotra, Alejandro Cane, Santiago M. C. Lopez
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
IntroductionWe compared hospitalization outcomes of young children hospitalized with COVID-19 to those hospitalized with influenza in the United States.MethodsPatients aged 0-
Externí odkaz:
https://doaj.org/article/aa559cc258c64e8d91044e939e5e75a2
Autor:
Manuela Di Fusco, Xiaowu Sun, Mary M. Moran, Henriette Coetzer, Joann M. Zamparo, Laura Puzniak, Mary B. Alvarez, Ying P. Tabak, Joseph C. Cappelleri
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-13 (2022)
Abstract Background Although there is extensive literature on the clinical benefits of COVID-19 vaccination, data on humanistic effects are limited. This study evaluated the impact of SARS-CoV-2 infection on symptoms, Health-Related Quality of Life (
Externí odkaz:
https://doaj.org/article/8b679ec97b3a4c20960feb168d34ae01
Autor:
Teresa K. Yamana, Marta Galanti, Sen Pei, Manuela Di Fusco, Frederick J. Angulo, Mary M. Moran, Farid Khan, David L. Swerdlow, Jeffrey Shaman
Publikováno v:
PLoS ONE, Vol 18, Iss 4 (2023)
By August 1, 2022, the SARS-CoV-2 virus had caused over 90 million cases of COVID-19 and one million deaths in the United States. Since December 2020, SARS-CoV-2 vaccines have been a key component of US pandemic response; however, the impacts of vacc
Externí odkaz:
https://doaj.org/article/e6b38ab3378c462e98efa2900ec8f5e8
Autor:
Erica Chilson, Daniel A. Scott, Beate Schmoele-Thoma, Wendy Watson, Mary M. Moran, Raul Isturiz
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 11, Pp 2758-2772 (2020)
Immunocompromising conditions increase the risk of invasive pneumococcal disease (IPD). Vaccine uptake in patients with these conditions may be low in part because of concerns about decreased immunogenicity and safety in these high-risk groups. We co
Externí odkaz:
https://doaj.org/article/e2526bd06d9d4a5e8b9126dbfa9a8b9e
Publikováno v:
Vaccines, Vol 10, Iss 12, p 2039 (2022)
Although pediatric populations experienced lower COVID-19 severity and mortality than adults, the epidemiology of this disease continues to evolve. COVID-19 clinical manifestations in pediatrics commonly include fever and cough, but may differ from a
Externí odkaz:
https://doaj.org/article/375305781928454f8f356bba162aa97f
Autor:
Jakob Langer, Verna L. Welch, Mary M. Moran, Alejandro Cane, Santiago M. C. Lopez, Amit Srivastava, Ashley L. Enstone, Amy Sears, Kristen J. Markus, Maria Heuser, Rachel M. Kewley, Isabelle J. Whittle
Publikováno v:
Advances in Therapy. 40:1601-1627
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e55586fcf0797b83fc192e233c174e2
https://doi.org/10.1007/s12325-023-02432-1
https://doi.org/10.1007/s12325-023-02432-1
Autor:
Manuela Di Fusco, Kinga Marczell, Kristen A. Deger, Mary M. Moran, Timothy L. Wiemken, Alejandro Cane, Solène de Boisvilliers, Jingyan Yang, Shailja Vaghela, Julie Roiz
Publikováno v:
Journal of Medical Economics. 25:605-617
As the body of evidence on COVID-19 and post-vaccination outcomes continues to expand, this analysis sought to evaluate the public health impact of the Pfizer-BioNTech COVID-19 Vaccine, BNT162b2, during the first year of its rollout in the US. A comb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be653fc1dbb3738ad20ce0dd8fd27837
https://doi.org/10.1080/13696998.2022.2071427
https://doi.org/10.1080/13696998.2022.2071427
Autor:
Jeffrey T Vietri, Martine C Maculaitis, Joseph C Cappelleri, Holly Yu, Lewis Kopenhafer, Mary M Moran, Kathleen Beusterien
Publikováno v:
Open Forum Infectious Diseases. 9
Background Vaccine recommendations in the United States (US) are made using the Evidence to Recommendation framework, which incorporates values and preferences of the target population. Vaccines for Clostridioides difficile infection (CDI) are in dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4aee52f85b4be535f38c0301eb7c45e
https://doi.org/10.1093/ofid/ofac492.195
https://doi.org/10.1093/ofid/ofac492.195
Autor:
Teresa K. Yamana, Marta Galanti, Sen Pei, Manuela Di Fusco, Frederick J. Angulo, Mary M. Moran, Farid Khan, David L. Swerdlow, Jeffrey Shaman
By August 1, 2022, the SARS-CoV-2 virus had caused over 90 million cases of COVID-19 and one million deaths in the United States. Since December 2020, SARS-CoV-2 vaccines have been a key component of US pandemic response; however, the impacts of vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5855aafa53c96f1b7f700c72cc3e9f86
https://doi.org/10.1101/2022.09.23.22280281
https://doi.org/10.1101/2022.09.23.22280281
